Navigation Links
Boston University School of Medicine awarded grants to improve early detection of lung cancer
Date:12/14/2010

(Boston)- Researchers from Boston University School of Medicine (BUSM) have been awarded a five-year, $2 million grant from the National Cancer Institute (NCI) Early Detection Research Network (EDRN), as well as a four-year, $1.3 million grant from the Department of Defense (DOD). These grants will allow the scientists to develop novel and complementary procedures for early detection of lung cancer in high-risk patients.

The grant from NCI will support collaboration between the University of California-Los Angeles and Boston University to form a Lung Cancer Biomarker Development Laboratory (UCLA-BU BDL) as part of the NCI EDRN program. The focus of the Boston University portion of this research program is designed to develop new tests for diagnosing lung cancer based on subtle cancer-related differences in cells from the nose or mouth.

"The idea is that even though these cells aren't cancerous, they act differently in patients with cancer and we can use these differences to diagnose disease," said Marc Lenburg, PhD, one of the principal investigators on the grant and an associate professor of medicine and pathology at BUSM.

The Boston University researchers will use sophisticated genomic approaches that measure the activity of each gene to detect the differences between patients with and without cancer. By drawing from the vast academic and clinical resources at the two institutions, the UCLA-BU BDL will advance new discoveries and transform them into early detection tools for lung cancer.

The DOD grant will fund collaborative research involving researchers at Boston University, UCLA, MD Anderson, and Vanderbilt University. This project also focuses on novel tests for the early detection of lung cancer, and will study veterans. Veterans are 75 percent more likely to develop lung cancer than civilian adults and also more likely to die from the disease.

The researchers will collect cells from the airways of veterans that have been damaged by smoking and develop a test that can detect differences in the healing of these injuries that might be related to lung cancer. This could ultimately allow for the detection of early signs of lung cancer in cells from the mouth, nose and throat that can be easily collected from smokers at risk for developing the disease. The work will further research into how lung cancer develops and on novel cancer therapies that target this process.

"The challenge is to develop lung cancer detection methods that are effective during this early window of opportunity to increase the rate of early detection and thereby spur early treatment and improve lung cancer patient outcomes," said Avrum Spira, MD, principal investigator on both grants and an associate professor of medicine and pathology at BUSM.


'/>"/>

Contact: Nathan Bliss
nathan.bliss@bmc.org
617-638-8490
Boston University Medical Center
Source:Eurekalert

Related medicine news :

1. Boston University researcher lauded for leading-edge lung cancer research efforts
2. Boston, Oct. 21-24: Largest international pediatric oncology conference
3. Boston Medical Center receives 2 grants for integrative medicine research
4. Boston Medical Center research study validates the Boston Bowel Preparation Scale
5. eMindful Provides a New Twist on Chocolate for Members of Boston's Beacon Hill Village
6. 25th AIDS Walk Boston to Take Place Sunday, June 6, 2010
7. Boston Children's Museum Lunch & Learn Lecture Series
8. Village at Proprietors Green Opens on South Shore, Introducing Innovative Senior Living to Boston Area
9. Vietnamese Student Named UMass Boston JFK Award Winner
10. Save the date: American Chemical Society National Meeting in Boston, Aug. 22-26
11. Keeping the Boston Bruins Healthy. Their New - Very Cold - Secret Weapon Against Injuries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... ... December 03, 2016 , ... The Lymphoma Research Foundation (LRF) ... and serving the lymphoma community through a comprehensive series of education programs, outreach ... in New York City, with long-time partners The Paul Foundation, on November 10, ...
(Date:12/4/2016)... ... 04, 2016 , ... "Pro3rd Displace is a set of ... displacement design elements," said Christina Austin - CEO of Pixel Film Studios. ... of design styles that include both left aligned and right aligned options for ...
(Date:12/2/2016)... ... ... Lori G. Cohen and Sara K. Thompson , shareholders in global ... Institute’s 21st Drug & Medical Device Litigation Conference , taking place in New York ... who chairs the firm’s Pharmaceutical, Medical Device & Health Care Litigation Practice and the ...
(Date:12/2/2016)... ... 02, 2016 , ... Advanced Inc., a leading provider of travel therapy and ... to serve as Advanced Inc.’s Chief Financial Officer, effective December 1, 2016. Jason previously ... financial and operational leadership experience to Advanced Inc. He began his career in finance ...
(Date:12/2/2016)... ... December 02, 2016 , ... With the number of pain management programs ... patients must find the one that works for them. When an inventor from Suisun ... that worked and decided to share it with others. , He developed a prototype ...
Breaking Medicine News(10 mins):
(Date:12/4/2016)... N.J. , Dec. 3, 2016  Findings ... and safety of CTL019, an investigational chimeric antigen ... (r/r) pediatric and young adult patients with B-cell ... during an oral session at the 58th American ... December 3, 4:00-5:30 p.m.). The global Phase II ...
(Date:12/2/2016)... bioLytical Laboratories, un líder mundial en test rápidos de ... Self Test , a los miembros de la Kenya Pharmaceutical Association. ... ... INSTI HIV Self Test! (PRNewsFoto/bioLytical Laboratories) ... (Photo: http://photos.prnewswire.com/prnh/20161201/444905 ) bioLytical fue invitada por la Clinton ...
(Date:12/2/2016)... According to the latest market report ... Automated Endoscope Reprocessors: Single Basin Automated Endoscope Reprocessors Product Type ... and 2024 " the global automated endoscope reprocessors market was valued at US$ ... a CAGR of 7.2% during an eight-year forecast period 2016-2024, ... 2024. ...
Breaking Medicine Technology: